Clinical spectrum and outcomes of mononeuritis multiplex in rheumatic diseases: evidence from a nationwide multicenter study

Firdevs Ulutaș, Meysere Nur Akuç, Burcu Yağız, Belkıs Nihan Coșkun, Yavuz Pehlivan, Kevser Bakırcı, Servet Yolbaș, Zeynel Abidin Akar, Dilek Tezcan, Ayșe Elif Boncukcuoğlu, Cemal Bes, Gülșah Yamancan, Ahmet Karataș, Akın Ișık, Fatma Alibaz Öner, Burak Okyar, Alper Yıldırım, Fatih Albayrak, Orhan Zengin, Esra Saydam Karabıyık, Gözde Yıldırım Çetin, Saliha Sunkak, Selime Ermurat, Özlem Kılıç, Abdulsamet Erden, İbrahim Yahya Çakır, Ali Ekin, Özlem Kudaș, Alperen Mengi, Mustafa Gür, șule Ketenci Ertaș, Lütfi Akyol, Zeynep Kaya, Adem Küçük, Osman Cüre, Mesude Seda Aydoğdu, Ayșenur Bayındır Akbaș, Veli Çobankara, Bünyamin Kısacık

Therapeutic Advances in Musculoskeletal Disease

Published online on August 01, 2026

Abstract

Therapeutic Advances in Musculoskeletal Disease, Volume 18, January-December 2026.
Background:Mononeuritis multiplex (MM) is a severe and clinically heterogeneous form of peripheral neuropathy, most commonly arising in the context of systemic vasculitis in rheumatology practice. Despite its potential to cause substantial functional ...